Epidemiological trends and risk attribution of early-onset liver cancer: insights from the Global Burden of Disease study 2021

Less developed countries bear a heavy burden of early-onset liver cancer, necessitating more effective interventions. Meanwhile, the escalating NASH-related early-onset liver cancer burden highlights the preventive potential of weight control, especially in high-income regions where a high body-mass index predominates.